Gilead Statement on New CDC Guidelines on Twice-Yearly Yeztugo® (Lenacapavir) for HIV Prevention
-3h 16m
-2d
Statement of Changes in Beneficial Ownership (Form 4)
-2d
Statement of Changes in Beneficial Ownership (Form 4)
-2d
-3d
-3d
Notice of Proposed Sale of Securities (Form 144)
-3d
Notice of Proposed Sale of Securities (Form 144)
-3d
-6d
Statement of Changes in Beneficial Ownership (Form 4)
9/11